Table 1. Baseline characteristics of study population.
| Item | Tranexamic acid group (n = 93) |
Control group (n = 92) |
p -value |
|---|---|---|---|
| Gender, % | 0.126 | ||
| Male | 9 (9.7) | 16 (17.4) | |
| Female | 84 (90.3) | 76 (82.6) | |
| Mean age, year | 34.7 ± 3.75 | 33.8 ± 3.14 | 0.961 |
| Mean weight, kg | 116.2 ± 10.6 | 112.8 ± 9.12 | 0.458 |
| Mean height, cm | 165.6 ± 4.4 | 168.2 ± 5.4 | 0.712 |
| Mean body mass index, kg/m2 | 41.1 ± 2.8 | 40.2 ± 2.5 | 0.246 |
| History of hypertension | 19 (20.4) | 17 (18.5) | 0.746 |
| History of diabetes | 6 (6.4) | 4 (4.3) | 0.342 |
| History of hyperlipidemia | 12 (12.9) | 9 (9.7) | 0.740 |
| Current smoking | 6 (6.4) | 7 (7.6) | 0.821 |
| Using antihypertensive drug | 17 (18.2) | 15 (16.3) | 0.665 |
| Using hypoglycemic drug | 6 (6.4) | 3 (3.2) | 0.229 |
| Laboratory indices | |||
| Serum hemoglobin, gr/dL | 11.8 ± 1.6 | 11.4 ± 1.8 | 0.856 |
| White blood count, /mm3 | 9,600.4 ± 982.3 | 10,700.6 ± 1,012.2 | 0.224 |
| Platelet count, /mm3 | 386.4 ± 22.7 | 354.7 ± 20.6 | 0.621 |
| Fasting blood sugar, mg/dL | 96.6 ± 4.5 | 94.2 ± 3.9 | 0.126 |
| Fasting high-density lipoprotein, mg/dL | 36.4 ± 2.3 | 38.8 ± 2.9 | 0.256 |
| Fasting low-density lipoprotein, mg/dL | 99.7 ± 12.1 | 97.5 ± 10.6 | 0.244 |
| Serum creatinine, mg/dL | 0.99 ± 0.02 | 0.98 ± 0.04 | 0.723 |
Source: Elaborated by the authors.